Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.519 SEK | +4.74% | +3.59% | -55.64% |
04-19 | AegirBio Unit Begins Arbitration Proceedings vs Salofa for Breach of Contract | MT |
04-09 | AegirBio Signs Conditional Agreement for SEK45 Million Loan With Atlas | MT |
Sales 2021 | 13.28 144.89 18.12 | Sales 2022 | 1.71 18.61 2.33 | Capitalization | 42.8M 467M 58.41M |
---|---|---|---|---|---|
Net income 2021 | -92M -1B -126M | Net income 2022 | -363M -3.96B -495M | EV / Sales 2021 | 72,019,947 x |
Net cash position 2021 | 32.63M 356M 44.53M | Net cash position 2022 | 7.44M 81.11M 10.15M | EV / Sales 2022 | 20,730,843 x |
P/E ratio 2021 |
-9.29
x | P/E ratio 2022 |
-0.11
x | Employees | 13 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 89.58% |
1 day | +4.74% | ||
1 week | +3.59% | ||
Current month | -29.24% | ||
1 month | -29.24% | ||
3 months | -44.79% | ||
6 months | -40.99% | ||
Current year | -55.64% |
Managers | Title | Age | Since |
---|---|---|---|
Marco Witteveen
CEO | Chief Executive Officer | - | 23-06-14 |
Director of Finance/CFO | - | 23-04-18 | |
Vasiliki Fragkou
COO | Chief Operating Officer | - | 10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 20-01-31 | |
Chairman | 67 | 19-11-30 | |
Sofia Bertling
BRD | Director/Board Member | 54 | 22-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.519 | +4.74% | 38,405 |
24-04-25 | 0.4955 | +0.92% | 95,441 |
24-04-24 | 0.491 | -1.80% | 323,437 |
24-04-23 | 0.5 | -5.30% | 205,924 |
24-04-22 | 0.528 | +5.39% | 287,230 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 11:13 am
More quotes1st Jan change | Capi. | |
---|---|---|
-55.64% | 1.46M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- AEGIR Stock